About this partner
BlueAllele is working to address the unmet therapeutic challenges in gene editing. Our approach is based on the core principles of innovating and developing the next level of safe and effective treatments for patients with genetic disorders.
In the Know: Healthcare News for June 27, 2022
BlueAllele® Corporation Continues to Advance Therapeutic Approaches Using Novel Gene Correction Technologies and Secures Third Patent from the USPTO?
In the Know: Healthcare News for February 28, 2022
BlueAllele Corporation Secures Second Patent from USPTO Strengthening the Company’s Position in Targeted Insertion and Gene Correction Technologies